The Alabama Senate on Tuesday passed House Bill 2, legislation that banned tianeptine in the state of Alabama. The Senate Judiciary Committee had added a controversial amendment to the bill that would have also banned tetrahydrocannabinol Delta-8 and Delta-10. The hemp industry complained that that amendment to the legislation would have adversely impacted them. That amendment was removed from HB2 at the request of the amendment’s author, state Sen. Arthur Orr, R-Decatur.
A similar amendment was proposed by state Rep. Arnold Mooney, R-Indian Springs, to the medical marijuana bill, SB46. The Mooney amendment, which was recommended by state Attorney General Steve Marshall, was rejected by the House Health Committee. The Mooney amendment would have made all the tetrahydrocannabinols a controlled substance in the state of Alabama. The bill’s sponsor, Sen. Tim Melson, R-Florence, asked that the Mooney amendment be tabled by the committee.
Delta-8 tetrahydrocannabinol derived from hemp is the hottest segment of the hemp industry right now. Delta-9 tetrahydrocannabinol is the psychoactive component of marijuana. It is banned under both federal and Alabama law. SB46, the Compassion Act, if passed by the Legislature, would make marijuana (Delta 9) available to people with a demonstrated medical need; but would be tightly regulated and controlled.
The Alabama Cannabis Industry Association thanked legislators for their work in defeating the two amendments and the House Health Committee for passing SB46.
“We would like to thank Senator Tom Whatley, Senator Roger D. Smitherman, & Senator Author Orr, along with all the Senators who worked with us in removing the amendment from HB2 that would have ban Delta-8 & Delta-10, in a unanimous vote,” Alabama Cannabis Industry Association President Chey Garrigan said. “We would also like to thank the members of the House Health Committee, who defeated an amendment to the medical cannabis bill